Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region. Tecnis PureSee is a purely refractive, presbyopia-correcting intraocular lens (IOL). It features a proprietary design aimed at delivering uninterrupted, high-quality vision. Johnson & Johnson says it offers high best-in-category contrast and low-light performance compared to a […]
Optical/Ophthalmic
Zeiss, Topcon settle trade secret theft lawsuit
Carl Zeiss Meditec said today that it reached a favorable resolution to settle a lawsuit against Topcon subsidiaries regarding trade secrets. The company’s suit against Topcon’s U.S.-based subsidiaries had been pending in the U.S. federal court for the Northern District of California. Zeiss said the settlement reinforces the protection of its trade secrets and “restores […]
Sight Sciences closes $65M credit facility
Sight Sciences (Nasdaq:SGHT) announced that it closed a senior secured credit facility worth up to $65 million. The credit facility with Hercules Capital includes the immediate draw of $35 million. Menlo Park, California–based Sight Sciences used the proceeds to pay off the principal amount of debt to its previous secured lender. In addition to the […]
FDA approves Zeiss software that treats nearsightedness
Zeiss Medical Technology announced that the FDA approved the VisuMax 800 with Smile Pro software. The Carl Zeiss Meditec unit designed the software to treat nearsightedness, with or without astigmatism. Its latest generation of femtosecond lasers enters the U.S. market with more than 8 million eyes already treated with Smile software. “The increasing global adoption […]
Carl Zeiss Meditec enhances ophthalmic portfolio with $1B acquisition
Carl Zeiss Meditec announced today that it entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center. The Germany-based company acquired DORC from the France-based investment firm Eurazeo. It expects the acquisition to enhance and complement its broad ophthalmic portfolio and range of digitally connected workflow solutions. The company develops […]
FDA approves Glaukos iDose TR glaucoma-treating drug delivery implant
Glaukos (NYSE:GKOS) announced today that the FDA approved a New Drug Application (NDA) for its iDose TR implant. The approval allows for one administration per eye of iDose TR (travoprost intracameral implant) 75 mcg. The indication for the prostaglandin analog covers the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OHT) or open-angle […]
Zilia earns FDA clearance for retinal camera
Zilia announced today that it received FDA 510(k) clearance for its Ocular FC retinal camera for non-invasive ocular assessments. Quebec City, Canada-based Zilia designed the Ocular FC system for assessing ocular biomarkers. The company believes it could “transform the diagnosis and management of ocular diseases,” according to a news release. It said the FDA clearance […]
Alcon stock dips on Q3 misses, tightened guidance
Alcon shares fell this morning on third-quarter results that missed the consensus forecast. Shares of ALC dipped 6.9% at $69.82 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The Geneva, Switzerland–based eye care device company posted profits of $204 […]
iStar Medical continues European MINIject rollout with first procedures in Ireland
iStar Medical announced today that it expanded the commercial rollout of its MINIject device with the first implants in Ireland. MINIject, a minimally invasive glaucoma surgery (MIGS) device, treats open-angle glaucoma. Currently the only commercially available supraciliary MIGS implant, it has demonstrated meaningful and sustained performance, plus a favorable safety profile. The device combines the […]
FDA issues warning about over-the-counter eye drops
The FDA issued a notice warning consumers about 26 over-the-counter eye drop products that could result in eye infections. In its notice, the FDA instructed consumers not to purchase and to immediately stop using these products. Using those eye drops could lead to the risk of infections that could result in partial vision loss or […]
Pixium Vision looks for a buyer
Pixium Vision this week said it launched a tender process for the purpose of finding buyers to acquire the company’s business. The company has been unable to find financial investors within the restricted timeframe and in line with Pixium Vision’s needs. Pixium Vision is requesting the conversion of safeguard proceedings into receivership. The deadline for […]